Thermo Fisher Scientific Inc (NYSE: TMO) has reported earnings for its fourth fiscal quarter (ending December 31) of $4.79 versus $4.22 for the same period a year ago — an increase of 14%. For the latest four quarters through December 31, E.P.S. were $16.58 versus $15.52 for the same period a year ago — an increase of 7%.
Recent Price Action
On 1/30/25, Thermo Fisher Scientific Inc (NYSE: TMO) stock enjoyed a very large increase of 6.8%, closing at $606.74. Moreover, this advance was accompanied by unusually high trading volume at 165% of normal. Relative to the market the stock has been weak over the last nine months but has risen 5.6% during the last week.
Current PriceTarget Research Rating
Thermo Fisher Scientific has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Thermo Fisher Scientific has a neutral Appreciation Score of 42 and a slightly negative Power Rating of 39, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment